Skip to content

Acupuncture therapy for myalgia-type temporomandibular joint disorders and its central mechanisms

Acupuncture therapy for myalgia-type temporomandibular joint disorders and its central mechanisms

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000769
Enrollment
Unknown
Registered
2025-04-17
Start date
2025-04-30
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Temporomandibular Disorders

Interventions

Healthy control group:No intervention
Acupuncture group:Acupuncture points: Xiaguan cheek car Tinggong cheeks pamper Hegu sun Operation method: The patient is in the supine position after the routine disinfection of the skin of the local
Sham acupuncture group:Sham acupuncture needles (0.25×40 mm, stainless steel with blunt tips) were applied to acupoints (identical to the acupuncture group) in supine patients for 30 minutes following

Sponsors

Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for TMDM in DC/TMD; 2. Patients with VAS pain score =4 points; 3. Patients aged 18-60 years old who can cooperate with treatment and examination; 4. Have not received acupuncture treatment in other hospitals or institutions; 5. Have not received TMDM related treatment in the past month; 6. Right hand; 7. Those who signed the informed consent form cooperated with the treatment and were able to complete all the treatment as planned; 8.?Inclusion Criteria for Healthy Control Group?: 1) No diagnosis of any temporomandibular joint disorders (including TMDM) according to DC/TMD criteria; 2) Absence of pain or dysfunction in the temporomandibular joint region (VAS pain score =1); 3) Age 18–60 years right-handed; 4) Gender ratio matched to the treatment group; 5) No severe underlying systemic diseases (normal cardiac pulmonary hepatic and renal function); 6) No temporomandibular joint-related treatments or pharmacological interventions within the past month; 7) Signed informed consent with commitment to comply with the study protocol.

Exclusion criteria

Exclusion criteria: 1. History of temporomandibular joint trauma or surgery; 2. Temporomandibular tumors autoimmune osteoarticular system diseases; 3. Patients with serious underlying diseases (such as heart lung liver and kidney dysfunction) or severe life-threatening; 4. People taking specific drugs (such as those who are taking antidepressant or anti-schizophrenic drugs or those who are taking non-steroidal anti-inflammatory drugs and muscle relaxants at the same time); 5. Special populations (such as pregnant women patients with coagulation dysfunction and easy bleeding etc.); 6. There are other diseases and factors that cannot be treated together; 7.The exclusion criteria for the healthy control group align with the aforementioned exclusion criteria for the treatment group.

Design outcomes

Primary

MeasureTime frame
regional homogeneity;Functional Connectivity;visual analogue scale;amplitude of low-frequency fluctuation;

Secondary

MeasureTime frame
Pressure Pain Threshold;Maximum active mouth opening;Jaw Functional Limitation Scale;

Countries

China

Contacts

Public ContactJiamei Mei

Hangzhou Hospital of Traditional Chinese Medicine

Chujiamei73@163.com1316152740

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026